Bile Acid Metabolism and Signaling
The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Abstract
Bile acids are important physiological agents for intestinal nutrient absorption and biliary secretion of lipids, toxic metabolites, and xenobiotics. Bile acids also are signaling molecules and metabolic regulators that activate nuclear receptors and G protein‐coupled receptor (GPCR) signaling to regulate hepatic lipid, glucose, and energy homeostasis and maintain metabolic homeostasis. Conversion of cholesterol to bile acids is critical for maintaining cholesterol homeostasis and preventing accumulation of cholesterol, triglycerides, and toxic metabolites, and injury in the liver and other organs. Enterohepatic circulation of bile acids from the liver to intestine and back to the liver plays a central role in nutrient absorption and distribution, and metabolic regulation and homeostasis. This physiological process is regulated by a complex membrane transport system in the liver and intestine regulated by nuclear receptors. Toxic bile acids may cause inflammation, apoptosis, and cell death. On the other hand, bile acid‐activated nuclear and GPCR signaling protects against inflammation in liver, intestine, and macrophages. Disorders in bile acid metabolism cause cholestatic liver diseases, dyslipidemia, fatty liver diseases, cardiovascular diseases, and diabetes. Bile acids, bile acid derivatives, and bile acid sequestrants are therapeutic agents for treating chronic liver diseases, obesity, and diabetes in humans. © 2013 American Physiological Society. Compr Physiol 3:1191‐1212, 2013.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · cited 1×
“The progression of NAFLD to NASH requires at least “two-hits,” hepatic steatosis is the first hit, followed by inflammation as the second hit (45).”
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Self-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Targeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421025 · Cited by 1,397
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 1×
“Bile acids also play a protective role in controlling bacterial overgrowth in the intestine (89).”
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,093
Strautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Farnesoid X receptor is essential for normal glucose homeostasis
Ma, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25604 · Cited by 882
Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 2×
“OCA antagonizes NF-κB-stimulated inflammation in liver (203), modulates innate immunity in animal models of colitis (197), inhibits and preserves the intestinal barrier in inflammatory bowel disease (69), and inhibits vascular smooth muscle cell inflammation and migration (119).”
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13656 · Cited by 793
Peroxisomal and Mitochondrial Defects in the Cerebro-Hepato-Renal Syndrome
Goldfischer, S., Moore, C. L., Johnson, A. B., Spiro, A. J., Valsamis, M. P., Wisniewski, H. K., Ritch, R. H., Norton, W. T., Rapin, I., & Gartner, L. M. (1973) · Science · doi:10.1126/science.182.4107.62 · Cited by 791
Katsuma, S., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.139 · Cited by 789 · cited 1×
“Knockdown of TGR5 mRNA expression by siRNA GLP-1 secretion suggesting that bile acids induce GLP-1 secretion by TGR5-dependent cAMP production (95).”
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
Calkin, A. C., & Tontonoz, P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3312 · Cited by 779 · cited 1×
“Many studies have implicated FXR in the regulation of bile acid synthesis, biliary bile acid secretion, intestinal bile acid absorption, and hepatic uptake of bile acids (24, 55, 106, 133, 172, 221).”
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
Shimomura, I., Bashmakov, Y., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 708
Molecular Pathogenesis of Cholestasis
Trauner, M., Meier, P. J., & Boyer, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391707 · Cited by 706
Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K. F., Donahee, M., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 696
Bile acids as regulatory molecules
Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., & Dent, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900007-jlr200 · Cited by 694
The bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655
Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639
Nuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 636
TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
Pols, T. W. H., Nomura, M., Harach, T., Lo Sasso, G., Oosterveer, M. H., Thomas, C., Rizzo, G., Gioiello, A., Adorini, L., Pellicciari, R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.006 · Cited by 610
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
Patti, M., Houten, S. M., Bianco, A. C., Bernier, R., Larsen, P. R., Holst, J. J., Badman, M. K., Maratos‐Flier, E., Mun, E. C., Pihlajamaki, J., et al. (2009) · Obesity · doi:10.1038/oby.2009.102 · Cited by 591
Endocrine functions of bile acids
Houten, S. M., Watanabe, M., & Auwerx, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601049 · Cited by 580
Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M., Williams, P. M., Soriano, R., Corpuz, R., Moffat, B., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1671 · Cited by 579
Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576
The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice
Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T. H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J.-C., Gonzalez, F. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510258200 · Cited by 552
Chen, G., Liang, G., Ou, J., Goldstein, J. L., & Brown, M. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404297101 · Cited by 551
ADD1/SREBP-1c Is Required in the Activation of Hepatic Lipogenic Gene Expression by Glucose
Foretz, M., Pacot, C., Dugail, I., Lemarchand, P., Guichard, C., le Lièpvre, X., Berthelier-Lubrano, C., Spiegelman, B., Kim, J. B., Ferré, P., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3760 · Cited by 548
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 546
Self-citationMyant, N. B., & Mitropoulos, K. A. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41693-1 · Cited by 520
The Farnesoid X Receptor: A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism
Claudel, T., Staels, B., & Kuipers, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000178994.21828.a7 · Cited by 504
Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors
Chiang, J. Y. L. (2002) · Endocrine Reviews · doi:10.1210/er.2000-0035 · Cited by 484
Self-citationWang, Y.-D., Chen, W.-D., Yu, D., Forman, B. M., & Huang, W. (2011) · Hepatology · doi:10.1002/hep.24525 · Cited by 480
Yabe, D., Brown, M. S., & Goldstein, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162488899 · Cited by 478
Redundant Pathways for Negative Feedback Regulation of Bile Acid Production
Wang, L., Lee, Y.-K., Bundman, D., Han, Y., Thevananther, S., Kim, C.-S., Chua, S. S., Wei, P., Heyman, R. A., Karin, M., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00187-9 · Cited by 476
Pathology of Nonalcoholic Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2007) · American Journal of Clinical Pathology · doi:10.1309/rtpm1py6ygbl2g2r · Cited by 469
Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C., Salen, G., Shefer, S., Batta, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215387 · Cited by 457
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
Pols, T. W. H., Noriega, L. G., Nomura, M., Auwerx, J., & Schoonjans, K. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.004 · Cited by 454
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Keitel, V., Donner, M., Winandy, S., Kubitz, R., & Häussinger, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.171 · Cited by 418 · cited 1×
“TGR5 is not expressed in hepatocytes, but has been detected in Kupffer cells (hepatic resident macrophages), liver sinusoidal endothelial cells, and gallbladder epithelial cells (97, 98, 100).”
Cipriani, S., Mencarelli, A., Palladino, G., & Fiorucci, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m001602 · Cited by 416
Song, K., Li, T., Owsley, E., Strom, S., & Chiang, J. Y. L. (2009) · Hepatology · doi:10.1002/hep.22627 · Cited by 414
Self-citationLUNDÅSEN, T., GÄLMAN, C., ANGELIN, B., & RUDLING, M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01731.x · Cited by 405
Shaham, O., Wei, R., Wang, T. J., Ricciardi, C., Lewis, G. D., Vasan, R. S., Carr, S. A., Thadhani, R., Gerszten, R. E., & Mootha, V. K. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.50 · Cited by 399
Regulation of bile acid synthesis
Chiang, J. Y. L. (1998) · Frontiers in Bioscience · doi:10.2741/a273 · Cited by 393
Self-citationPournaras, D. J., Glicksman, C., Vincent, R. P., Kuganolipava, S., Alaghband-Zadeh, J., Mahon, D., Bekker, J. H. R., Ghatei, M. A., Bloom, S. R., Walters, J. R. F., et al. (2012) · Endocrinology · doi:10.1210/en.2011-2145 · Cited by 383
Cipriani, S., Mencarelli, A., Chini, M. G., Distrutti, E., Renga, B., Bifulco, G., Baldelli, F., Donini, A., & Fiorucci, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025637 · Cited by 382 · cited 2×
“Bile acidactivated FXR and TGR5 signaling suppress inflammation in macrophages, intestine, and hepatocytes by inhibiting NF-κB nuclear translocation and antagonizing NF-κB-dependent induction of proinflammatory cytokines (36, 63, 146, 197).”
Dawson, P. A., Hubbert, M., Haywood, J., Craddock, A. L., Zerangue, N., Christian, W. V., & Ballatori, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412752200 · Cited by 381
Setchell, K. D., Schwarz, M., O'Connell, N. C., Lund, E. G., Davis, D. L., Lathe, R., Thompson, H. R., Weslie Tyson, R., Sokol, R. J., & Russell, D. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2962 · Cited by 375
Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., & Fukamizu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314322200 · Cited by 364
Bile acids: regulation of apoptosis by ursodeoxycholic acid
Amaral, J. D., Viana, R. J. S., Ramalho, R. M., Steer, C. J., & Rodrigues, C. M. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900011-jlr200 · Cited by 363
Kerr, T. A., Saeki, S., Schneider, M., Schaefer, K., Berdy, S., Redder, T., Shan, B., Russell, D. W., & Schwarz, M. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00154-5 · Cited by 351
Yu, C., Wang, F., Kan, M., Jin, C., Jones, R. B., Weinstein, M., Deng, C.-X., & McKeehan, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15482 · Cited by 350
Obesity, Insulin Resistance, and Cardiovascular Disease
Reaven, G. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.207 · Cited by 348
Lang, C., Meier, Y., Stieger, B., Beuers, U., Lang, T., Kerb, R., Kullak-Ublick, G. A., Meier, P. J., & Pauli-Magnus, C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230418.28091.76 · Cited by 339
Kast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 336
Zollner, G., Marschall, H.-U., Wagner, M., & Trauner, M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 335
Ballatori, N., Christian, W. V., Lee, J. Y., Dawson, P. A., Soroka, C. J., Boyer, J. L., Madejczyk, M. S., & Li, N. (2005) · Hepatology · doi:10.1002/hep.20961 · Cited by 335
Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT
Carlton, V. E. H., Harris, B. Z., Puffenberger, E. G., Batta, A. K., Knisely, A. S., Robinson, D. L., Strauss, K. A., Shneider, B. L., Lim, W. A., Salen, G., et al. (2003) · Nature Genetics · doi:10.1038/ng1147 · Cited by 329
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Prawitt, J., Abdelkarim, M., Stroeve, J. H. M., Popescu, I., Duez, H., Velagapudi, V. R., Dumont, J., Bouchaert, E., van Dijk, T. H., Lucas, A., et al. (2011) · Diabetes · doi:10.2337/db11-0030 · Cited by 326
Conjugated Bile Acids Activate the Sphingosine–1–Phosphate Receptor 2 in Primary Rodent Hepatocytes
Studer, E., Zhou, X., Zhao, R., Wang, Y., Takabe, K., Nagahashi, M., Pandak, W. M., Dent, P., Spiegel, S., Shi, R., et al. (2012) · Hepatology · doi:10.1002/hep.24681 · Cited by 320
Regulation of gene expression by SREBP and SCAP
Edwards, P. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00140-2 · Cited by 316
Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307145200 · Cited by 312 · cited 1×
“FXR, PXR and constitutive androstane receptor (CAR) may play a complementary role in detoxification of bile acids and protection against cholestasis (76).”
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
Keitel, V., Reinehr, R., Gatsios, P., Rupprecht, C., Görg, B., Selbach, O., Häussinger, D., & Kubitz, R. (2007) · Hepatology · doi:10.1002/hep.21458 · Cited by 310
Davidson, M. H., Dillon, M. A., Gordon, B., Jones, P., Samuels, J., Weiss, S., Isaacsohn, J., Toth, P., & Burke, S. K. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1893 · Cited by 307
Deciphering the nuclear bile acid receptor FXR paradigm
Modica, S., Gadaleta, R. M., & Moschetta, A. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08005 · Cited by 295
The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders #
Keitel, V., Cupisti, K., Ullmer, C., Knoefel, W. T., Kubitz, R., & Häussinger, D. (2009) · Hepatology · doi:10.1002/hep.23032 · Cited by 290
Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor
Stayrook, K. R., Bramlett, K. S., Savkur, R. S., Ficorilli, J., Cook, T., Christe, M. E., Michael, L. F., & Burris, T. P. (2005) · Endocrinology · doi:10.1210/en.2004-0965 · Cited by 288
Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 288
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Porez, G., Prawitt, J., Gross, B., & Staels, B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024794 · Cited by 286
Schaap, F. G., van der Gaag, N. A., Gouma, D. J., & Jansen, P. L. M. (2009) · Hepatology · doi:10.1002/hep.22771 · Cited by 284
Liver-specific Activities of FGF19 Require Klotho beta
Lin, B. C., Wang, M., Blackmore, C., & Desnoyers, L. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704244200 · Cited by 283
Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR)
Sonoda, J., Xie, W., Rosenfeld, J. M., Barwick, J. L., Guzelian, P. S., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212494599 · Cited by 281
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
Vassileva, G., Golovko, A., Markowitz, L., Abbondanzo, S. J., Zeng, M., Yang, S., Hoos, L., Tetzloff, G., Levitan, D., Murgolo, N. J., et al. (2006) · Biochemical Journal · doi:10.1042/bj20060537 · Cited by 277
Pauli-Magnus, C., Lang, T., Meier, Y., Zodan-Marin, T., Jung, D., Breymann, C., Zimmermann, R., Kenngott, S., Beuers, U., Reichel, C., et al. (2004) · Pharmacogenetics · doi:10.1097/00008571-200402000-00003 · Cited by 273
Detoxification of Lithocholic Acid, A Toxic Bile Acid: Relevance to Drug Hepatotoxicity
Hofmann, A. F. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033475 · Cited by 268
The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
Li, T., Holmstrom, S. R., Kir, S., Umetani, M., Schmidt, D. R., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0460 · Cited by 264
New molecular insights into the mechanisms of cholestasis
Wagner, M., Zollner, G., & Trauner, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.012 · Cited by 260
Pellicciari, R., Gioiello, A., Macchiarulo, A., Thomas, C., Rosatelli, E., Natalini, B., Sardella, R., Pruzanski, M., Roda, A., Pastorini, E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901390p · Cited by 260
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Adorini, L., Pruzanski, M., & Shapiro, D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.012 · Cited by 259
Glucose Regulates the Expression of the Farnesoid X Receptor in Liver
Duran-Sandoval, D., Mautino, G., Martin, G., Percevault, F., Barbier, O., Fruchart, J.-C., Kuipers, F., & Staels, B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.890 · Cited by 257
van Mil, S. W. C., Milona, A., Dixon, P. H., Mullenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A. G., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257
Setchell, K. D., Suchy, F. J., Welsh, M. B., Zimmer-Nechemias, L., Heubi, J., & Balistreri, W. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113837 · Cited by 255
Watanabe, M., Horai, Y., Houten, S. M., Morimoto, K., Sugizaki, T., Arita, E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248203 · Cited by 254
Effects of Diabetes Mellitus on Cholesterol Metabolism in Man
Bennion, L. J., & Grundy, S. M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706162962401 · Cited by 253
Engelking, L. J., Kuriyama, H., Hammer, R. E., Horton, J. D., Brown, M. S., Goldstein, J. L., & Liang, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20978 · Cited by 249
Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho
Ito, S., Fujimori, T., Furuya, A., Satoh, J., Nabeshima, Y., & Nabeshima, Y.-I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23076 · Cited by 248
Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1)
Zhang, M., & Chiang, J. Y. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105117200 · Cited by 247
Self-citationLi, T., Owsley, E., Matozel, M., Hsu, P., Novak, C. M., & Chiang, J. Y. L. (2010) · Hepatology · doi:10.1002/hep.23721 · Cited by 245
Self-citationBhalla, S., Ozalp, C., Fang, S., Xiang, L., & Kemper, J. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405423200 · Cited by 230
Metabolic Syndrome: Focus on Dyslipidemia
Ginsberg, H. N., Zhang, Y., & Hernandez‐Ono, A. (2006) · Obesity · doi:10.1038/oby.2006.281 · Cited by 228
Li, T., Matozel, M., Boehme, S., Kong, B., Nilsson, L.-M., Guo, G., Ellis, E., & Chiang, J. Y. L. (2011) · Hepatology · doi:10.1002/hep.24107 · Cited by 224
Self-citationLi, T., & Chiang, J. Y. L. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00258.2004 · Cited by 218
Self-citationClayton, P. T., Leonard, J. V., Lawson, A. M., Setchell, K. D., Andersson, S., Egestad, B., & Sjövall, J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112915 · Cited by 215
Zhang, Y., Breevoort, S. R., Angdisen, J., Fu, M., Schmidt, D. R., Holmstrom, S. R., Kliewer, S. A., Mangelsdorf, D. J., & Schulman, I. G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59817 · Cited by 213
Glucose and Insulin Induction of Bile Acid Synthesis
Li, T., Francl, J. M., Boehme, S., Ochoa, A., Zhang, Y., Klaassen, C. D., Erickson, S. K., & Chiang, J. Y. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.305789 · Cited by 212
Self-citationBays, H. E., Goldberg, R. B., Truitt, K. E., & Jones, M. R. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.18.1975 · Cited by 212
De Fabiani, E., Mitro, N., Gilardi, F., Caruso, D., Galli, G., & Crestani, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305079200 · Cited by 210
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
Bhatnagar, S., Damron, H. A., & Hillgartner, F. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808818200 · Cited by 209
FXR signaling in metabolic disease
Zhang, Y., & Edwards, P. A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.015 · Cited by 209
Li, Y. C., Wang, D. P., & Chiang, J. Y. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38501-1 · Cited by 209
Self-citationDeBose-Boyd, R. A., Ou, J., Goldstein, J. L., & Brown, M. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1477 · Cited by 209
Integration of TGF-ß and Ras/MAPK Signaling Through p53 Phosphorylation
Cordenonsi, M., Montagner, M., Adorno, M., Zacchigna, L., Martello, G., Mamidi, A., Soligo, S., Dupont, S., & Piccolo, S. (2007) · Science · doi:10.1126/science.1135961 · Cited by 203
Brufau, G., Stellaard, F., Prado, K., Bloks, V. W., Jonkers, E., Boverhof, R., Kuipers, F., & Murphy, E. J. (2010) · Hepatology · doi:10.1002/hep.23831 · Cited by 198
Goldberg, R. B. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1531 · Cited by 197
Pellicciari, R., Costantino, G., Camaioni, E., Sadeghpour, B. M., Entrena, A., Willson, T. M., Fiorucci, S., Clerici, C., & Gioiello, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049904b · Cited by 194
Gadaleta, R. M., Oldenburg, B., Willemsen, E. C. L., Spit, M., Murzilli, S., Salvatore, L., Klomp, L. W. J., Siersema, P. D., van Erpecum, K. J., & van Mil, S. W. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.005 · Cited by 192
Chen, F., Ananthanarayanan, M., Emre, S., Neimark, E., Bull, L. N., Knisely, A. S., Strautnieks, S. S., Thompson, R. J., Magid, M. S., Gordon, R., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.013 · Cited by 191
The bile acid sensor FXR regulates insulin transcription and secretion
Renga, B., Mencarelli, A., Vavassori, P., Brancaleone, V., & Fiorucci, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.01.002 · Cited by 189
Angelin, B., Einarsson, K., Hellström, K., & Leijd, B. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40685-6 · Cited by 179
Setchell, K. D. R., Heubi, J. E., Bove, K. E., O'Connell, N. C., Brewsaugh, T., Steinberg, S. J., Moser, A., & Squires, R. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50017 · Cited by 176
Bile???Acid???Sequestrants???and???the???Treatment of Type??2??Diabetes??Mellitus
Staels, B., & Kuipers, F. (2007) · Drugs · doi:10.2165/00003495-200767100-00001 · Cited by 176
Defects of Bile Acid Synthesis in Zellweger's Syndrome
Hanson, R. F., Szczepanik-VanLeeuwen, P., Williams, G. C., Grabowski, G., & Sharp, H. L. (1979) · Science · doi:10.1126/science.424737 · Cited by 174
Disorders of bile acid synthesis
Clayton, P. T. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9259-3 · Cited by 172
Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration
Li, Y. T. Y., Swales, K. E., Thomas, G. J., Warner, T. D., & Bishop-Bailey, D. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.152694 · Cited by 171
Jacquemin, E. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-19033 · Cited by 171
Li, T., Jahan, A., & Chiang, J. Y. L. (2006) · Hepatology · doi:10.1002/hep.21183 · Cited by 168
Self-citationBile Salt–Induced Apoptosis Involves NADPH Oxidase Isoform Activation
Reinehr, R., Becker, S., Keitel, V., Eberle, A., Grether‐Beck, S., & Häussinger, D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.023 · Cited by 164
Wasmuth, H. E., Glantz, A., Keppeler, H., Simon, E., Bartz, C., Rath, W. H., La, M., Marschall, H., & Lammert, F. (2006) · Gut · doi:10.1136/gut.2006.092742 · Cited by 164
Moustafa, T., Fickert, P., Magnes, C., Guelly, C., Thueringer, A., Frank, S., Kratky, D., Sattler, W., Reicher, H., Sinner, F., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.09.051 · Cited by 163
Beysen, C., Murphy, E. J., Deines, K., Chan, M., Tsang, E., Glass, A., Turner, S. M., Protasio, J., Riiff, T., & Hellerstein, M. K. (2012) · Diabetologia · doi:10.1007/s00125-011-2382-3 · Cited by 163
Miyake, J. H., Wang, S.-L., & Davis, R. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000275200 · Cited by 162
27-Hydroxycholesterol: production rates in normal human subjects
Duane, W. C., & Javitt, N. B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33481-7 · Cited by 156
Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
Thomas, C., Auwerx, J., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 154
Wang, L., Liu, J., Saha, P. K., Huang, J., Chan, L., Spiegelman, B. M., & Moore, D. D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.010 · Cited by 154
ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy
Müllenbach, R., Bennett, A., Tetlow, N., Patel, N., Hamilton, G., Cheng, F., Chambers, J., Howard, R., Taylor-Robinson, S., & Williamson, C. (2005) · Gut · doi:10.1136/gut.2004.058115 · Cited by 151
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146
Noé, J., Kullak-Ublick, G. A., Jochum, W., Stieger, B., Kerb, R., Haberl, M., Müllhaupt, B., Meier, P. J., & Pauli‐Magnus, C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.020 · Cited by 143
FXR, a Bile Acid Receptor and Biological Sensor
Tu, H., Okamoto, A. Y., & Shan, B. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00043-8 · Cited by 142
Wittenburg, H., Lyons, M. A., Li, R., Churchill, G. A., Carey, M. C., & Paigen, B. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01053-9 · Cited by 141
Kullak-Ublick, G. A., & Meier, P. J. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70114-8 · Cited by 140
Fang, Y., Han, S. I., Mitchell, C., Gupta, S., Studer, E., Grant, S., Hylemon, P. B., & Dent, P. (2004) · Hepatology · doi:10.1002/hep.1840400427 · Cited by 139
Bile acids: the role of peroxisomes
Ferdinandusse, S., Denis, S., Faust, P. L., & Wanders, R. J. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900009-jlr200 · Cited by 134
Ballatori, N., Fang, F., Christian, W. V., Li, N., & Hammond, C. L. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90319.2008 · Cited by 131
Miao, J., Xiao, Z., Kanamaluru, D., Min, G., Yau, P. M., Veenstra, T. D., Ellis, E., Strom, S., Suino-Powell, K., Xu, H. E., et al. (2009) · Genes & Development · doi:10.1101/gad.1773909 · Cited by 126
Lemonde, H. A., Custard, E. J., Bouquet, J., Duran, M., Overmars, H., Scambler, P. J., & Clayton, P. T. (2003) · Gut · doi:10.1136/gut.52.10.1494 · Cited by 125
Dent, P., Fang, Y., Gupta, S., Studer, E., Mitchell, C., Spiegel, S., & Hylemon, P. B. (2005) · Hepatology · doi:10.1002/hep.20942 · Cited by 125
Keitel, V., Nies, A. T., Brom, M., Hummel-Eisenbeiss, J., Spring, H., & Keppler, D. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2002 · Cited by 124
Han, S., & Chiang, J. Y. L. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025155 · Cited by 120
Self-citationThe Role of FXR in Disorders of Bile Acid Homeostasis
Eloranta, J. J., & Kullak-Ublick, G. A. (2008) · Physiology · doi:10.1152/physiol.00020.2008 · Cited by 119
A Role of the Bile Salt Receptor FXR in Atherosclerosis
Hageman, J., Herrema, H., Groen, A. K., & Kuipers, F. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197897 · Cited by 119
Cai, S., Gautam, S., Nguyen, T., Soroka, C. J., Rahner, C., & Boyer, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.025 · Cited by 117
Δ4-3-Oxosteroid 5β-reductase deficiency causing neonatal liver failure and hemochromatosis
Shneider, B. L., Setchell, K. D. R., Whitington, P. F., Neilson, K. A., & Suchy, F. J. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70310-8 · Cited by 116
Transgenic Expression of Cholesterol-7-α-Hydroxylase Prevents Atherosclerosis in C57BL/6J Mice
Miyake, J. H., Duong-Polk, X. T., Taylor, J. M., Du, E. Z., Castellani, L. W., Lusis, A. J., & Davis, R. A. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.102588 · Cited by 115
Alvarez, L., Jara, P., Sánchez-Sabaté, E., Hierro, L., Larrauri, J., Díaz, M. C., Camarena, C., De la Vega, A., Frauca, E., López-Collazo, E., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh261 · Cited by 114
Shang, Q., Saumoy, M., Holst, J. J., Salen, G., & Xu, G. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2009 · Cited by 110
Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation
Fiorucci, S., Cipriani, S., Mencarelli, A., Renga, B., Distrutti, E., & Baldelli, F. (2010) · Current Molecular Medicine · doi:10.2174/1566524011009060579 · Cited by 110
Schwarz, M., Wright, A. C., Davis, D. L., Nazer, H., Björkhem, I., & Russell, D. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10902 · Cited by 109
Regulation of the mouse organic solute transporter α-β, Ostα-Ostβ, by bile acids
Frankenberg, T., Rao, A., Chen, F., Haywood, J., Shneider, B. L., & Dawson, P. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00479.2005 · Cited by 108
Genetic cholestasis, causes and consequences for hepatobiliary transport
Jansen, P. L. M., & Sturm, E. (2003) · Liver International · doi:10.1034/j.1478-3231.2003.00856.x · Cited by 107
Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice
Uppal, H., Toma, D., Saini, S. P. S., Ren, S., Jones, T. J., & Xie, W. (2005) · Hepatology · doi:10.1002/hep.20512 · Cited by 106
Lang, T., Haberl, M., Jung, D., Drescher, A., Schlagenhaufer, R., Keil, A., Mornhinweg, E., Stieger, B., Kullak-Ublick, G. A., & Kerb, R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008854 · Cited by 104
Yu, C., Wang, F., Jin, C., Huang, X., & McKeehan, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411771200 · Cited by 103
Pellicciari, R., Sato, H., Gioiello, A., Costantino, G., Macchiarulo, A., Sadeghpour, B. M., Giorgi, G., Schoonjans, K., & Auwerx, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070633p · Cited by 103
PGC-1α Activates CYP7A1 and Bile Acid Biosynthesis
Shin, D.-J., Campos, J. A., Gil, G., & Osborne, T. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309736200 · Cited by 102
Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy
Painter, J. N., Savander, M., Ropponen, A., Nupponen, N. N., Riikonen, S., Ylikorkala, O., Lehesjoki, A., & Aittomäki, K. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201355 · Cited by 100
Brufau, G., Groen, A. K., & Kuipers, F. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181206 · Cited by 95
The Role of α1-Fetoprotein Transcription Factor/LRH-1 in Bile Acid Biosynthesis
del Castillo-Olivares, A., Campos, J. A., Pandak, W. M., & Gil, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400646200 · Cited by 95
Insulin Regulation of Cholesterol 7α-Hydroxylase Expression in Human Hepatocytes
Li, T., Kong, X., Owsley, E., Ellis, E. C. S., Strom, S. C., & Chiang, J. Y. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605815200 · Cited by 87
Self-citationAngelin, B., Einarsson, K., Hellström, K., & Leijd, B. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40684-4 · Cited by 84
Lundåsen, T., Liao, W., Angelin, B., & Rudling, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302645200 · Cited by 84
Cytokine regulation of human sterol 12α-hydroxylase (CYP8B1) gene
Jahan, A., & Chiang, J. Y. L. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2004 · Cited by 81
Self-citationGlucose stimulates cholesterol 7α-hydroxylase gene transcription in human hepatocytes
Li, T., Chanda, D., Zhang, Y., Choi, H.-S., & Chiang, J. Y. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002782 · Cited by 80
Self-citationBile Acid Synthetic Defects and Liver Disease
Bove, K. E., Daugherty, C. C., Tyson, W., Mierau, G. W., Heubi, J. E., Balistreri, W. F., & Setchell, K. D. R. (2000) · Pediatric and Developmental Pathology · doi:10.1007/s100240050001 · Cited by 76
Inborn Errors of Bile Acid Synthesis
Setchell, K. D. R., & Street, J. (1987) · Seminars in Liver Disease · doi:10.1055/s-2008-1040568 · Cited by 76
Wilkinson, D. S., Ogden, S. K., Stratton, S. A., Piechan, J. L., Nguyen, T. T., Smulian, G. A., & Barton, M. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1200-1212.2005 · Cited by 76
PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts
He, J., Nishida, S., Xu, M., Makishima, M., & Xie, W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.055 · Cited by 76
Biliary and nonbiliary contributions to reverse cholesterol transport
Temel, R. E., & Brown, J. M. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283508c21 · Cited by 73
Song, K. H., Ellis, E. C. S., Strom, S. C., & Chiang, J. Y. L. (2007) · Hepatology · doi:10.1002/hep.21878 · Cited by 71
Self-citationSong, K., & Chiang, J. Y. L. (2006) · Hepatology · doi:10.1002/hep.20919 · Cited by 70
Self-citationSubramaniam, P., Clayton, P. T., Portmann, B. C., Mieli‐Vergani, G., & Hadžić, N. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181b47b34 · Cited by 70
Gonzales, E., Cresteil, D., Baussan, C., Dabadie, A., Gerhardt, M.-F., & Jacquemin, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.024 · Cited by 68
Bile acid‐CoA ligase deficiency—a new inborn error of bile acid metabolism
Chong, C. P. K., Mills, P. B., McClean, P., Gissen, P., Bruce, C. K., Stahlschmidt, J., Knisely, A. S., & Clayton, P. T. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9416-3 · Cited by 65
The ins and outs of reverse cholesterol transport
Groen, A., Oude Elferink, R., Verkade, H., & Kuipers, F. (2004) · Annals of Medicine · doi:10.1080/07853890310020635 · Cited by 63
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
“Specifically, the discovery of the bile acid receptors farnesoid X receptor (FXR), Takeda G-coupled protein receptor 5 (TGR5; GPBAR1, M-BAR), pregnane X receptor (PXR), sphingosine-1-phosphate receptor 2 (S1PR2), the muscarinic receptors M2/3, and the vitamin D receptor have established bile acids as multifunctional s…”
BackgroundBile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
“Recently, therapies targeted to FXR, TGR5, and bile acid metabolism have been developed for treatment of metabolic diseases and cholestatic liver diseases (reviewed in Claudel et al., 2004; Trauner and Halilbasic, 2011; Fiorucci et al., 2012; Porez et al., 2012; Chiang, 2013; Li and Chiang, 2013; Swanson et al., 2013;…”
BackgroundSelf-citation
Metadata
- Authors
- Chiang, J. Y. L.
- Venue
- Comprehensive Physiology
- Publisher
- Wiley
- Published
- 2013-07
- Volume
- 3
- Issue
- 3
- Pages
- 1191-1212
- ISSN
- 2040-4603 (ISSN-L)
- OpenAlex
- W4409112878
- Cited by
- 279
- References
- 224
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.